Mesenchymal stem cells (Beijing Yuanhefa Biotechnology)

间充质干细胞（北京源和发生物）

Report date: 2024/12/20 15:05:13

Base Information

Drug NameMesenchymal stem cells (Beijing Yuanhefa Biotechnology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Yuanhefa Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeda International Cardiovascular HospitalBeijing Yuanhefa Biotechnology Co Ltd
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A